Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton Sep 19, 2023 6:20pm
286 Views
Post# 35644332

RE:Bored. Waiting. Here is some playing with data to look at.

RE:Bored. Waiting. Here is some playing with data to look at. It seems clear that if a patient does not have a CR at 90 days the treatment is ultimately not going to work for them. That's 24 out of 57 patients or 42%. I don't think it's lilkely that all of these patients have upper urinary tract carcinoma, so why doesn't the treatment work for them?

It may not be of much interest right now but in the future maybe they can discover what is different about those patients, the NRs and IRs without UUTC, and find an optimization for this subgroup. Perhaps some patients require a greater dose of Ruvidar or a longer light exposure (within the limits of safety). If those patients can be identified ahead of time maybe more of then can be effectively treated.

DJDawg wrote: I like playing around with patterns. Here is a URL pic of what I made recently as there is nothing else to do for now.

I took the swimmers plot and other data to generate a table to see some patterns.
-What do the under-treated 12 look like?
-What do the patients who start CR look like?
-What do the patients who start IR look like?
-What do the patients who start NR look like?

I tend to focus on the pure CR's that stay that way as they are different than the rest.

Love any corrections or feedback.

https://i.postimg.cc/tgpKJXvh/TLT-data-discussion.png


<< Previous
Bullboard Posts
Next >>